MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...
On World Cancer Day 2026, oncologists spoke about the early signs of prostate cancer, which are often mistaken for ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...
An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results